Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
After finishing at $185.39 in the prior trading day, Quest Diagnostics, Inc (NYSE: DGX) closed at $187.35, up 1.06%. In other words, the price has increased by $1.06 from its previous closing price. On the day, 1.03 million shares were traded. DGX stock price reached its highest trading level at $188.1 during the session, while it also had its lowest trading level at $185.45.
Ratios:
Our goal is to gain a better understanding of DGX by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 65.67 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 17.12. For the most recent quarter (mrq), Quick Ratio is recorded 0.99 and its Current Ratio is at 1.09. In the meantime, Its Debt-to-Equity ratio is 0.88 whereas as Long-Term Debt/Eq ratio is at 0.79.
On April 02, 2025, Redburn Atlantic started tracking the stock assigning a Buy rating and target price of $195.
Citigroup Downgraded its Buy to Neutral on March 04, 2025, while the target price for the stock was maintained at $185.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 26 ’25 when PREVOZNIK MICHAEL E sold 227 shares for $188.13 per share. The transaction valued at 42,706 led to the insider holds 38,117 shares of the business.
PREVOZNIK MICHAEL E bought 227 shares of DGX for $42,706 on Sep 26 ’25. On Sep 23 ’25, another insider, PREVOZNIK MICHAEL E, who serves as the SVP & General Counsel of the company, sold 28,288 shares for $187.12 each. As a result, the insider received 5,293,313 and left with 38,117 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DGX now has a Market Capitalization of 20950122496 and an Enterprise Value of 27133122560. As of this moment, Quest’s Price-to-Earnings (P/E) ratio for their current fiscal year is 22.40, and their Forward P/E ratio for the next fiscal year is 18.15. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.92. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.99 while its Price-to-Book (P/B) ratio in mrq is 2.90. Its current Enterprise Value per Revenue stands at 2.579 whereas that against EBITDA is 13.184.
Stock Price History:
The Beta on a monthly basis for DGX is 0.59, which has changed by 0.25772023 over the last 52 weeks, in comparison to a change of 0.14201736 over the same period for the S&P500. Over the past 52 weeks, DGX has reached a high of $191.49, while it has fallen to a 52-week low of $146.91. The 50-Day Moving Average of the stock is 3.07%, while the 200-Day Moving Average is calculated to be 8.79%.
Shares Statistics:
The stock has traded on average 964.80K shares per day over the past 3-months and 900020 shares per day over the last 10 days, according to various share statistics. A total of 112.00M shares are outstanding, with a floating share count of 111.28M. Insiders hold about 0.49% of the company’s shares, while institutions hold 97.67% stake in the company. Shares short for DGX as of 1759190400 were 4328978 with a Short Ratio of 4.49, compared to 1756425600 on 4249168. Therefore, it implies a Short% of Shares Outstanding of 4328978 and a Short% of Float of 4.42.
Dividends & Splits
In the trailing 12 months, DGX’s forward annual dividend rate was 3.1, compared to 3.15 this year. Against a Trailing Annual Dividend Yield of 0.016721506. The stock’s 5-year Average Dividend Yield is 1.86. The current Payout Ratio is 39.15% for DGX, which recently paid a dividend on 2025-10-03 with an ex-dividend date of 2025-10-03. Stock splits for the company last occurred on 2005-06-21 when the company split stock in a 2:1 ratio.
